Neuberger Berman Group Portfolio holdings
AUM
$130B
1-Year Return
22.03%
This Quarter Return
+7.64%
1 Year Return
+22.03%
3 Year Return
+86.29%
5 Year Return
+159.6%
10 Year Return
+388.21%
AUM
$108B
AUM Growth
+$5.83B
(+5.7%)
Cap. Flow
+$351M
Cap. Flow
% of AUM
0.33%
Top 10 Holdings %
Top 10 Hldgs %
14.94%
Holding
1,903
New
119
Increased
780
Reduced
810
Closed
95
Top Buys
| 1 |
Boston Scientific
BSX
|
+$253M |
| 2 |
Johnson & Johnson
JNJ
|
+$253M |
| 3 |
McDonald's
MCD
|
+$245M |
| 4 |
Exelon
EXC
|
+$215M |
| 5 |
Gilead Sciences
GILD
|
+$215M |
Top Sells
| 1 |
Parker-Hannifin
PH
|
+$235M |
| 2 |
Elevance Health
ELV
|
+$215M |
| 3 |
Constellation Brands
STZ
|
+$170M |
| 4 |
Johnson Controls International
JCI
|
+$167M |
| 5 |
Bank of America
BAC
|
+$161M |
Sector Composition
| 1 | Technology | 23.6% |
| 2 | Financials | 12.83% |
| 3 | Healthcare | 12.57% |
| 4 | Industrials | 11.46% |
| 5 | Consumer Discretionary | 8.4% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1076
ASE Group
ASX
$24.3B
| $2.03M | ﹤0.01% |
254,850
+12,363
| +5% | +$98.5K |
|
1077
iShares Russell 2000 Value ETF
IWN
$12B
| $2.01M | ﹤0.01% |
14,693
-111,561
| -88% | -$15.3M |
|
1078
Arcutis Biotherapeutics
ARQT
$2.12B
| $2.01M | ﹤0.01% |
183,015
+16,637
| +10% | +$183K |
|
1079
Dr. Reddy's Laboratories
RDY
$12.2B
| $2.01M | ﹤0.01% |
+176,935
| New | +$2.01M |
|
|
NETC
1080
DELISTED
Nabors Energy Transition Corp.
NETC
| $2M | ﹤0.01% |
+190,300
| New | +$2M |
|
1081
Teradyne
TER
$18.7B
| $2M | ﹤0.01% |
18,570
+452
| +2% | +$48.6K |
|
1082
Credo Technology Group
CRDO
$27.6B
| $1.99M | ﹤0.01% |
211,771
+62,239
| +42% | +$586K |
|
1083
iShares Core S&P Small-Cap ETF
IJR
$86.4B
| $1.97M | ﹤0.01% |
20,421
-12,010
| -37% | -$1.16M |
|
1084
Fortis
FTS
$24.7B
| $1.97M | ﹤0.01% |
46,345
-60
| -0.1% | -$2.55K |
|
1085
Baxter International
BAX
$12.5B
| $1.96M | ﹤0.01% |
48,438
+2,979
| +7% | +$121K |
|
1086
First Solar
FSLR
$22.2B
| $1.95M | ﹤0.01% |
8,986
+3,585
| +66% | +$780K |
|
1087
IAC Inc
IAC
$2.92B
| $1.95M | ﹤0.01% |
46,164
-2,598
| -5% | -$110K |
|
|
BPMC
1088
DELISTED
Blueprint Medicines
BPMC
| $1.94M | ﹤0.01% |
43,176
+3,736
| +9% | +$168K |
|
1089
JPMorgan BetaBuilders USD High Yield Corporate Bond ETF
BBHY
$617M
| $1.94M | ﹤0.01% |
43,226
-22,120
| -34% | -$994K |
|
1090
Jabil
JBL
$23.1B
| $1.93M | ﹤0.01% |
21,841
+2,953
| +16% | +$260K |
|
1091
RPM International
RPM
$16.3B
| $1.92M | ﹤0.01% |
22,007
-501
| -2% | -$43.7K |
|
1092
Northern Trust
NTRS
$24.5B
| $1.92M | ﹤0.01% |
21,757
+1,031
| +5% | +$90.9K |
|
1093
Banco Santander Chile
BSAC
$12.4B
| $1.92M | ﹤0.01% |
+107,206
| New | +$1.92M |
|
1094
Ryanair
RYAAY
$31.6B
| $1.9M | ﹤0.01% |
50,383
+70
| +0.1% | +$2.64K |
|
1095
Entergy
ETR
$39.9B
| $1.9M | ﹤0.01% |
35,242
+5,512
| +19% | +$297K |
|
1096
Bruker
BRKR
$4.78B
| $1.89M | ﹤0.01% |
24,016
+250
| +1% | +$19.7K |
|
1097
Outset Medical
OM
$249M
| $1.89M | ﹤0.01% |
6,844
-375
| -5% | -$104K |
|
1098
SPDR S&P Biotech ETF
XBI
$5.48B
| $1.86M | ﹤0.01% |
24,462
+301
| +1% | +$22.9K |
|
1099
Xcel Energy
XEL
$43B
| $1.86M | ﹤0.01% |
27,567
+1,440
| +6% | +$97.1K |
|
|
KRTX
1100
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
| $1.86M | ﹤0.01% |
10,235
+267
| +3% | +$48.5K |
|